Skip to main content

ADVERTISEMENT

Mauricio Arruda, MD

Original Contribution
01/28/2022
Percutaneous left atrial appendage occlusion (LAAO) with the Watchman device is FDA approved for stroke prevention in patients with nonvalvular atrial fibrillation who have an appropriate indication.
Percutaneous left atrial appendage occlusion (LAAO) with the Watchman device is FDA approved for stroke prevention in patients with nonvalvular atrial fibrillation who have an appropriate indication.
Percutaneous left atrial...
01/28/2022
Journal of Invasive Cardiology
Original Contribution
11/01/2021
A prospective analysis of 71 non-consecutive patients who underwent LAAO over an 18-month period with cardiac CTA-guided preprocedural planning and ICE was conducted.
A prospective analysis of 71 non-consecutive patients who underwent LAAO over an 18-month period with cardiac CTA-guided preprocedural planning and ICE was conducted.
A prospective analysis of 71...
11/01/2021
Journal of Invasive Cardiology